Skip to main content

Medical Marijuana

Victory! Congress lifts ban on Washington, D.C.'s medical marijuana law

Dear friends:

The great news just keeps coming in.

Minutes ago, Congress voted to finally lift the 11-year ban on Washington, D.C.’s medical marijuana law.

The House voted 221-202 and the Senate voted 57-35 to approve the measure.

For the last 11 years, under a provision known as the Barr amendment, Congress has prevented Washington, D.C. from implementing the medical marijuana law passed by 69% of voters in 1998.

Repealing this amendment has been a primary focus of MPP's federal lobbying efforts for many years. In 2007, we even hired former Congressman Bob Barr (R-Ga.) — the original author of the amendment — to lobby to overturn it. And our lobbyists have worked directly with members of the House and Senate and their staff since 2006 to eliminate this democracy-unfriendly law.

In fact, senior appropriators in Congress sought out MPP staff to work through specifics and to help better understand D.C.'s medical marijuana law and the complicated legal maneuverings that led to the blocking of its implementation.  

MPP would like to thank Congressmen Jose Serrano (D-N.Y.), Dave Obey (D-Wis.), Speaker Nancy Pelosi (D-Calif.), and Senate Majority Whip Dick Durbin (D-Ill.) for their strong and abiding support of allowing D.C. to implement its medical marijuana law.

I also want to thank MPP's 29,000 dues-paying members, whose support helped to make this win possible. If you'd like to see more of these kinds of successes, I hope you'll donate to MPP's federal lobbying efforts. We're turning supporters' donations into results, and we can't do it without you.

Today's vote represents a victory not just for medical marijuana patients, but for all Americans, who have the right to determine their own policies without federal meddling. We'll be celebrating this victory in D.C. at our anniversary gala on January 13, and I hope you'll join us.

Sincerely,

null

Rob Kampia?
Executive Director?
Marijuana Policy Project?
Washington, D.C.

P.S. Time is running out on our matching campaign! A major philanthropist has committed to match the first $2.35 million that MPP can raise in 2009. Make twice the impact and donate today.

Congress Ends Ban on Medical Marijuana in Washington, D.C.

FOR IMMEDIATE RELEASE                                                                                                                                 

DECEMBER 13, 2009

Congress Ends Ban on Medical Marijuana in Washington, D.C.

Only Obama’s Signature Now Needed on Historic Measure

CONTACT: Aaron Houston, MPP director of government relations ……………………… 202-420-1031

WASHINGTON, D.C. — The U.S. Senate today passed historic legislation to end the decade long ban on implementation of the medical marijuana law Washington, D.C. voters passed in 1998.

            “This marks the first time in history that Congress has changed a marijuana law for the better,” said Aaron Houston, director of government relations for the Marijuana Policy Project in Washington, D.C.

            The “Barr amendment,” a rider attached to appropriations for the District, has forbidden D.C. from extending legal protection to qualified medical marijuana patients and has long been derided as an unconscionable intrusion by the federal government into the District's affairs. The omnibus spending bill, now approved by both chambers of Congress, removes this onerous provision, allowing the District to finally implement its voter-approved law. President Obama is expected to sign the bill shortly.

          “This is not only a huge victory for medical marijuana patients and for D.C. self-government, it marks a history-making shift on the medical marijuana issue," Houston said. “This is the first time Congress has ever given its assent to a state or local law that permits medical use of marijuana. It shows that Congress is listening to voters, who have supported protection for medical marijuana patients for well over a decade, as well as to the medical community’s growing recognition of marijuana’s medical value.

         “Coming on top of the announcement that the Department of Justice will not interfere with state medical marijuana laws, this shows that the ground has fundamentally shifted. It’s time for the federal government to take the logical next step as the American Medical Association just suggested, and reconsider marijuana’s classification as a Schedule I drug, which bars medical use.”

         Congressman Jose Serrano (D-N.Y.) originally removed the ban from the D.C. appropriations bill back in July after years of working to protect patients in Washington, D.C. Congressman David Obey (D-Wis.) helped ensure that the change made it through the legislative process and into the omnibus spending bill Congress passed today.

         Medical marijuana is legal under the laws of 13 states, with bills under consideration in several others, including New York, New Jersey, and Illinois.

         With more than 29,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit http://MarijuanaPolicy.org.

####

The calls to Congress are working -- keep it up!

Friends:

The calls to Congress are working, and I've been getting great feedback from ASA activists.  Will you help?

Step by step, Congress is learning about the Truth in Trials Act. 

A good example is U.S. Representative Darrell Issa, who got a number of calls, emails, and letters from ASA activists in his Southern California district.   One such email came from ASA activist Joshua Lewis, who is Editor-in-Chief of the Medical Cannabis Journal. 

Congressman Issa sent the following response to Joshua:

-----
From: Congressman Darrell Issa
Sent: Thursday, December 03, 2009 10:29 AM
To: Joshua Lewis
Subject: Re: your recent message

Dear Mr. Lewis:

Thank you for taking the time to write to me to request my co sponsorship of the Truth in Trials Act

I have forwarded your letter to my Legislative Assistant who will investigate the possibility of cosponsoring this bill.

Thank you again for taking the time to bring your interest in this bill to my attention.

Sincerely,

Darrell Issa
Member of Congress
-----

Elected officials are starting to pay attention to what we are asking for.  Medical marijuana patients need protection from federal prosecution.  The Truth in Trials Act can help.

Will you call your Member of Congress?

Here's a reminder of the basic steps:

1. Find out who your Rep is.  Go to http://www.house.gov and type in your zip code in the upper left corner.  If it asks for your full "Zip+4", just look at your last piece of junk mail.

2. Dial 202-224-3121.  Ask the operator to transfer you to your Member of Congress.

3. Tell your Rep ... "I'm calling from ______ and I want you to cosponsor HR 3939, the Truth in Trials Act."

4. Reply to this email and tell me who you called.

Thanks!

- Sanjeev, ASA

ASA's 2009 Holiday Party -- Oakland, California

Americans for Safe Access 2009 Holiday Party

Wednesday, December 16th at 7:30 PM

Live Music with Brass Liberation Orchestra, DJs, Entertainment by Shamanic Cheerleaders, Silent Auction, Appetizers & Champagne.

Hosted by Steph Sherer, Executive Director & Founder of ASA
Screening of "Medical Cannabis in California: A report from the front-line"

Age 21+, Please Bring ID

Maxwell's Restaurant & Lounge
341 14th Street at Webster in Oakland

$25 Pre-sale tickets online:  www.americansforsafeaccess.org/holidayparty

Or call ASA's office at 510-251-1856

Press Release: Congress Close to Ending Ban on Medical Marijuana in Washington, D.C.

FOR IMMEDIATE RELEASE                                                                                              
DECEMBER 9, 2009

Congress Close to Ending Ban on Medical Marijuana in Washington, D.C.

CONTACT: Bruce Mirken, MPP director of communications …………… 415-585-6404 or 202-215-4205

WASHINGTON, D.C. — In a historic move, Congress is now poised to end the decade long ban on Washington, D.C. implementing the medical marijuana law District voters passed in 1998 with a 69 percent majority. Known as the Barr amendment, the provision – a rider attached to appropriations for the District -- has forbidden D.C. from extending legal protection to qualified medical marijuana patients and has been derided by advocates for years as an unconscionable intrusion by the federal government into the District's affairs.

            The omnibus spending bill that Democratic leaders will shortly be bringing to a vote in the House later this week removes this onerous provision. Once both chambers approve this final language and the president signs it, the Barr amendment will no longer block medical marijuana in D.C.

         "The end of the Barr amendment is now in sight,” said Aaron Houston, director of government relations for the Marijuana Policy Project in Washington. “This represents a huge victory not just for medical marijuana patients, but for all city residents who have every right to set their own policies in their own District without congressional meddling. D.C. residents overwhelmingly made the sensible, compassionate decision to pass a medical marijuana law, and now, more than 10 years later, suffering Washingtonians may finally be allowed to focus on treating their pain without fearing arrest."

            Advocates noted that the welcome repeal will come too late to help Jonathan Magbie, a D.C. quadriplegic man who died in prison in 2004 from lack of medical care after being convicted for using marijuana to treat his pain.

         "Jonathan Magbie would be alive today if the District been able to implement its medical marijuana law when it passed in 1998,” Houston said. "Perhaps now nobody in the District will ever have to suffer as he and his family did simply for using the medicine that works best for them."       

         Recently, the American Medical Association called on the federal government to reconsider marijuana’s classification as a Schedule I drug, which bars medical use.

         With more than 29,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit http://MarijuanaPolicy.org.

####

Exciting times for medical marijuana in Rhode Island!

Dear friend, Since 2003, the Rhode Island Patient Advocacy Coalition (RIPAC) has led the Rhode Island’s medical marijuana movement. This past year has been monumental with the passage of the compassion center legislation which will allow three state-regulated, not-for-profit, retail dispensaries in RI. This victory will help to ensure that RI patients will have safe and affordable access to their medicine and make the RI Medical Marijuana Act the best in the country. Even before this success in June 2009, RI and RIPAC have been receiving amazing press coverage and recently we were even featured in The New York Times. We have been responding to the national medical marijuana developments with such actions as my interview on WPRI/Fox Providence and press statement in response to the Obama Administration’s announcement last month protecting patients in medical marijuana states. This is AMAZING progress and we need your continued support! http://ripatients.org/Donate/ RIPAC has expanded our services and we are now conducting orientations to provide patients and caregivers with the skills they need to make the most of the program. We continue to hold multiple meetings every month to educate patients, caregivers and community members. These meetings have gotten bigger and our monthly cardholder meetings now consistently include more than 10% of the state’s population of medical marijuana patients. None of this could have been possible without your continuous support. As a very small nonprofit, RIPAC relies heavily on private donors like you. With your generous support we can continue our work to advocate for patients, help educate them to navigate the program and help them retain a better quality of life. Your contribution, of any size, is crucial for us to continue our work to preserve the rights of patients. http://ripatients.org/Donate/ We are reaching much of the community, but now more than ever, we still have more work to do. We need to continue educating medical professionals and RIPAC, along with Patients Out of Time, is accomplishing this by hosting an international Continuing Medical Education “Clinical Conference on Cannabis” at the Crown Plaza Hotel in Warwick, RI from April 15-17, 2010. We also need to educate law enforcement personnel to protect our patients and we need to make sure that the compassion centers have the patients’ best interests in mind. In this season of giving, founding executive director Jesse Stout and I ask you to contribute $50, $100, $250 today with a check or credit card or become a member of our “Advocacy Circle” with monthly donations of $50, $40, $25 or whatever you can afford. Our goal is to raise $30,000! You can help with your gift, which is tax-deductible, and you can conveniently give by visiting our website and donating in the upper right hand corner. http://ripatients.org/Donate/ Happy Holiday Season to all! Sincerely, Stephen Hogan Jr. & Jesse Stout

Press Release: National Boards of Pharmacy Conference Focuses on Medical Marijuana

FOR IMMEDIATE RELEASE: December 3, 2009 CONTACT: ASA Media Liaison Kris Hermes at 510-681-6361 National Boards of Pharmacy Conference Focuses on Medical Marijuana Advocacy Group Presents on Medical Marijuana Alongside AMA & Other Health Experts Tucson, AZ -- As pharmacists and drug regulators from across the country convene in Tucson this week for their Winter symposium, they will be discussing medical marijuana, an issue which is headlining the agenda. The National Association of Boards of Pharmacy (NABP) opens its symposium on Thursday with several presentations on medical marijuana by an array of speakers and experts, including Caren Woodson, Government Affairs Director with Americans for Safe Access, the country's largest advocacy organization focused on the issue. "We welcome the interest in medical marijuana by the Boards of Pharmacy and want to work with them to address this public health issue," said Woodson. "State Boards of Pharmacy can have an impact on medical marijuana and we want to work with them to adopt sensible policies." The Oregon Board of Pharmacy has been ordered to remove marijuana from its state list of Schedule I drugs, per legislation signed by Governor Kulongoski in August. In addition, the Iowa Board of Pharmacy is currently considering rescheduling marijuana as a result of litigation. Woodson will co-present on a panel Thursday morning with Barry D. Dickinson, the Director of Science & Biotechnology for the American Medical Association, and Alice Mead, the Director of U.S. Public Relations for GW Pharmaceuticals, a U.K. company conducting clinical trials for a medical marijuana extract. The panel is entitled, "Should Marijuana be a Medical Option?" Later, Woodson will take part in a point-counterpoint on medical marijuana with Dickinson, Mead and other experts, including Andrea Barthwell, former deputy director for the U.S. Office of National Drug Control Policy and other marijuana researchers. The NABP symposium will be attended by Boards of Pharmacy executive officers, members, and other state and federal regulators as well as stakeholders in the pharmaceutical industry. Both the California Attorney General's office and the California Department of Public Health are sending representatives to the symposium. Attendees will be able to earn continuing pharmacy education credit for their participation in medical marijuana panels. The mission of the NABP is to assist its member boards in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health. The State Boards of Pharmacy oversee the classification of controlled substances, such as marijuana, at the state level, similar to the way that the Food & Drug Administration (FDA) and the Drug Enforcement Administration (DEA) oversee the federal classification of controlled substances. While state controlled substance lists routinely match the federal list, the State Boards of Pharmacy can change the classification of particular drugs independent of the federal government. The NABP symposium follows a report on medical marijuana issued last month by the American Medical Association, in which the oldest and largest physician-based group in the U.S. urged the federal government to review the Schedule I status for marijuana. The AMA noted that marijuana appeared to be efficacious for several health conditions and said that further research was needed to assess whether marijuana should continue to be considered a dangerous drug with no medical value. Further Information: The National Association of Boards of Pharmacy 2009 Symposium Schedule: http://www.nabp.net/whatsnew/meetings/2009symposium/ ASA National Policy Platform: http://www.safeaccessnow.org/downloads/ASA_Natl_Policy_Agenda_09-11.pdf # # #

Congress is starting to listen...

Dear friends:

I wanted to say thank you to Sioux Colombe, an ASA Ambassador in Sacramento, California.  The email she received below demonstrates that Congress is starting to hear us.

Sioux had asked her Member of Congress, Representative Doris Matsui, to support the Truth in Trials Act.  Sioux got the response below, which is a perfect example of the kind of dialog we want to build with our elected officials.

This reply means that Rep. Matsui's office took the time to research the Truth in Trials Act and respond.  The next step is to ask Rep. Matsui to become a supporter -- a "cosponsor" -- of the bill.

Will you do the same for your U.S. Representative? 

If your Rep gets a phone call from you, they will start paying attention.

Here's what you have to do -- it will take 5 minutes.

1. Find out who your Rep is.  Go to http://www.house.gov and type in your zip code in the upper left corner.  If it asks for your full "Zip+4", just look at your last piece of junk mail.

2. Dial 202-224-3121.  Ask the operator to transfer you to your Member of Congress.

3. Tell your Rep ... "I'm calling from ______ and I want you to cosponsor HR 3939, the Truth in Trials Act."

4. Reply to this email and tell me who you called.

Thanks!

- Sanjeev, ASA

P.S.  The full email that Sioux received is below.


Sanjeev Bery
National Field Director
Americans for Safe Access


----- Forwarded Message ----
From: Congresswoman Doris O. Matsui
To: Sioux Colombe
Sent: Tue, December 1, 2009 12:22:29 PM
Subject: From the Office of Congresswoman Matsui


December 1, 2009 
 

Ms. Sioux Colombe
Sacramento, California

Dear Sioux:

Thank you for contacting me regarding medical marijuana.  I appreciate hearing from you on this issue.

As you may know, 13 states, including California, currently allow the use of marijuana for medical purposes.  In these jurisdictions, state-level penalties for the cultivation, possession, and use of medical marijuana have been removed, and programs to regulate patients' use have been established or are currently being considered.  However, in these 13 states where medical marijuana use is legal, users remain subject to federal penalties for such use.

In an effort to correct this, legislation has been introduced in the 111th Congress to permit the use of medical marijuana under federal law in states where marijuana is currently being used for medicinal purposes.  The Medical Marijuana Patient Protection Act (H.R. 2835), would achieve this end by re-classifying marijuana into a less restrictive category of drug under the regulatory structure of the Controlled Substances Act.

Another piece of legislation, the Truth in Trials Act (H.R. 3939), responds to the Justice Department's directive on medical marijuana policy, which tells federal prosecutors to avoid pursuing cases against individuals who legally use medical marijuana.  Specifically, H.R. 3939 would allow a person on trial for a federal marijuana-related offense to introduce evidence that the alleged marijuana-related activities were performed in compliance with state laws.

Again, thank you for taking the time to contact me regarding medical marijuana.  To learn more about my work in Congress, or to sign up for occasional e-mail updates, please visit my website at http://matsui.house.gov.


Sincerely,


DORIS O. MATSUI
Member of Congress

Patients Out of Time: Announcing a New Look

Announcing a new look to http://www.MedicalCannabis.com/ Patients Out of Time is pleased to notify the professional health care community of the most unique educational platform for the exploration of medicinal cannabis (marijuana) science in the United States. This site provides visitors with a wide array of information related to the efficacy of cannabis as medicine. Links are provided to the faculty and agendas of five past accredited clinical conferences and to Google video and You Tube video of over 50 academic presentations of world-wide cannabis related science. A link is provided for registration for media, exhibitors, health care professionals and the public for The Sixth National Clinical Conference on Cannabis Therapeutics to be held April 15-17, 2010 in Warwick (Providence), RI. The forum is co-sponsored by Patients Out of Time, the School of Medicine, University of California San Francisco , the Rhode Island State Nurses Association, and the Rhode Island Patient Advocacy Coalition (RIPAC). The forum will be located at the Crowne Plaza Hotel at the Crossings. Medical Doctors and Registered Nurses will also find continuing medical education credits (CME's) or continuing education contact hours available "on-line" that are based on clinical research conducted world-wide on the cannabis plant. These credits, authorized by the American Nurses Association and the American Medical Association are provided by the UCSF School of Medicine, Office of Continuing Education through a direct link on the web site. Journalists and other media representatives are advised to seek the opinion of medical professionals of great expertise in therapeutic cannabis treatments and the interpretation of new cannabis science rather than the traditional sources of cannabis information which are staffed by administrators and lobbyists, not medical professionals. The four United States federally supplied cannabis patients, medical doctors and registered nurses are available for interview or consultation with Patients Out of Time. Contact: Al Byrne, Co-founder Patients Out of Time, 501c3 educational charity 1472 Fish Pond Rd. Howardsville, VA 24562 E-mail: [email protected] Tel: (434) 263-4484 Fax: (434) 263-6753

Landmark Medical Marijuana Hearings Tomorrow in Harrisburg

FOR IMMEDIATE RELEASE

Pennsylvanians for Medical Marijuana

www.pa4mmj.org 

WHO: Pennsylvania House Health and Human Services committee

WHAT: Public Hearings on HB 1393, medical marijuana in PA

WHEN: December 2, 2009 Room 140 at 11AM, Main Capitol in Harrisburg

CONTACT: Chris Goldstein cellphone 505 577 5093 or email [email protected]

**UPDATE**

A Press Conference with Rep. Cohen and PA4MMJ patients will take place at 10:00AM at the East Rotunda

 

Landmark Medical Marijuana Hearings Tomorrow in Harrisburg

December 1, 2009

Philadelphia- Advocates and patients with the group Pennsylvanians for Medical Marijuana (PA4MMJ) will testify tomorrow before the PA House of Representatives Health and Human Services Committee during hearings on HB 1393, The Compassionate Use Medical Marijuana Act.

 

These will be the first public hearings on medical cannabis in the history of the Commonwealth.

On April 29, 2009 Rep. Mark B. Cohen introduced the bill to legalize medical marijuana with PA4MMJ. HB1393 would allow registered patients to grow six plants or purchase cannabis through Compassion Centers. A provision in the bill allows these medical cannabis sales to be taxed.

At a press conference at the bill’s introduction Cohen said, "It's time to create a new, honest image for marijuana. One as a form of treatment that when prescribed by responsible doctors could help thousands of patients across this commonwealth."

Three newspaper Editorial Boards endorsed the bill immediately after it was introduced: The Philadelphia Inquirer, The Pocono Record and the Daily Review of Towanda.

 

Testifying in favor of the bill: Chris Goldstein and Derek Rosenzweig of PA4MMJ; Ed Pane of Serento Gardens Treatment Center; Bradley Walter who lives with HIV; Andrew Hoover of the ACLU-PA, Criminal Defense Attorney Patrick Nightengale; MS patient John Wilson of New Jersey; Brian Gralnick of JSPAN; Bob Ceppecio of The Marijuana Policy Project along with other local patients and professionals. Signed written testimony from 26 PA residents will be presented by PA4MMJ along with 19 written submissions sent anonymously. Expert written submissions and comments came from the AIDS Law Project of Pennsylvania, the National Lawyers Guild Philadelphia Chapter, The Coalition for Medical Marijuana New Jersey and the National Organization for the reform of Marijuana Laws Deputy Director Paul Armentano.

Several groups will testify in opposition to medical cannabis including the PA Elks Association.

The December 2nd hearings are informational and will not see a vote. The twenty-six-member committee may ask questions of the presenters and PA4MMJ is expecting a lively and educational discussion. Please visit www.pa4mmj.org

MEDIA MAY CONTACT CHRIS GOLDSTEIN DIRECTLY [email protected]